Allergy Immunotherapy Market Report , Comprehensive Study Explores Huge Revenue Scope in Future 2027
Market Analysis
The Allergy
Immunotherapy Market Report is predicted to touch USD 4,
324.7 million at a 10.85% CAGR between 2016-2023, reveals the latest Market
Research Future (MRFR) report. Allergen immunotherapy or allergy shots, simply
put, is a long-term treatment that helps in decreasing symptoms for many with
stinging insect allergy, eye allergy, allergic asthma, and allergic rhinitis.
Its effectiveness rests on the dosage of the allergen and the duration of the
treatment program. This treatment is generally recommended for those suffering
from severe allergy symptoms, not responding to usual medications. Allergy
immunotherapy is also effective for those having side effects from medications,
those for whom allergies have become life-threatening, and people finding their
lives disrupted by allergies. Moreover, it also helps in reducing the severity
of reactions resulting from insect stings.
Various factors are propelling the
Allergy Immunotherapy Market Report growth. These factors, as stated by the
latest Market Research Future (MRFR) report, include increasing clinical
trials, new approvals, and R&D activities, growing number of allergic
patients, creation of new products for curing allergies, increased flow of
capital, growing awareness regarding the advantages of allergy immunotherapy,
and growing incidence of allergies such as food allergy, asthma, and allergy
rhinitis. Moreover, technological advancements and the growing number of
companies collaborating with independent research centers and hospitals for
developing innovative and new immunotherapy technologies are also adding to the
growth of the market.
On the flip side, limited
applications of allergy immunotherapy and restricted healthcare spending are
factors that may deter the Allergy Immunotherapy Market Report growth over the
forecast period.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1517
Market
Segmentation
The Market Research Future report
provides an all-inclusive segmental analysis of the Allergy Immunotherapy
Market Report on the basis of treatment and allergy type.
Based on allergy type, the Allergy
Immunotherapy Market Report is segmented into peanut allergy, allergic
rhinitis, allergic asthma, cat allergy, and other allergies. Of these, the
allergic rhinitis segment will have the largest share in the market during the
forecast period chiefly owing to its growing prevalence among children and
adults alike.
Based on treatment, the Allergy
Immunotherapy Market Report is segmented into specific immunotherapy (SIT),
subcutaneous immunotherapy (SCIT), and sublingual immunotherapy. The sublingual
immunotherapy segment is again segmented into sublingual immunotherapy drops
and sublingual immunotherapy tablets. Of these, the subcutaneous immunotherapy
segment will dominate the market during the forecast period. Factors pushing
the growth of this segment include its effectiveness in treating various types
of allergies, such as asthma. Moreover, this is a treatment option that alters
the immune system for preventing the development of other types of
allergies.
Regional
Analysis
By region, the Allergy
Immunotherapy Market Report report covers the latest trends and growth
opportunities across the Americas, the Middle East and Africa, the Asia
Pacific, and Europe. Of these, Europe will dominate the market over the
forecast period. Factors pushing the growth of the Allergy Immunotherapy Market
Report in the region include increasing incidence of various chronic diseases
such as hypertension, diabetes, allergy, and asthma, growing awareness about
allergy immunotherapy treatments, and elevated occurrence of skin allergy and
allergic rhinitis.
The Allergy Immunotherapy Market
Report in North America is predicted to have a healthy growth over the forecast
period owing to increasing awareness about allergy as well as its treatment
along with the availability of effective products.
The Allergy Immunotherapy Market
Report in the APAC region is predicted to have a significant growth during the
forecast period for rising awareness of treatments coupled with mounting
healthcare spending.
The global Allergy Immunotherapy
Market Report in the Middle East and Africa is predicted to have a small growth
over the forecast period.
Key Players
Major players profiled in the Allergy
Immunotherapy Market Report report include HAL Allergy Group (Netherlands),
Stallergenes Greer (UK), ALK Abello A/S (Denmark), DBV Technologies (France),
Circassia (UK), Merck KGaA (Allergopharma) (Germany), and Allergy Therapeutics
(UK), among others.
Industry News
October 2019: A graduate student
from the department of immunology in the Max Rady College of Medicine has
developed a new drug for combating allergic asthma.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/allergy-immunotherapy-market-1517
About US:
Market Research Future (MRFR), enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Comments
Post a Comment